SCHEMBL6667754

SCHEMBL6667754

CN(Cc1ccc(Cl)cc1)C(=O)c1n[nH]c2c(CN3CCSCC3)cc(CN3CCOCC3)cc2c1=O

nearest known ligand 0.39

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
AKR1C3 P42330 1/20 0.39
NR1H4 Q96RI1 1/20 0.38
CHEK1 O14757 2/20 0.37
POLA1 P09884 2/20 0.37
KCNH2 Q12809 5/20 0.37
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
LSS P48449 1/20 0.36
HCRTR1 O43613 1/20 0.36
HCRTR2 O43614 1/20 0.36
PDE1B Q01064 1/20 0.35
ENPP2 Q13822 1/20 0.35
HSP90AA1 P07900 1/20 0.35
HSP90AB1 P08238 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6667774 0.83 CHEK1 (0.46) AKR1C3NR1H4CHEK1POLA1KCNH2
SCHEMBL6667762 0.83 MEN1 (0.42) POLA1KCNH2RAB9A
SCHEMBL7478855 0.82 POLA1 (0.39) AKR1C3NR1H4CHEK1POLA1KCNH2
SCHEMBL6667470 0.82 INSR (0.39) AKR1C3NR1H4POLA1KCNH2NPC1
SCHEMBL7472513 0.82 AKR1C3 (0.36) AKR1C3NR1H4CHEK1POLA1KCNH2
SCHEMBL7007040 0.81 PDE1B (0.45) AKR1C3NR1H4CHEK1POLA1KCNH2
SCHEMBL6669285 0.81 POLA1 (0.35) AKR1C3NR1H4POLA1KCNH2NPC1
SCHEMBL7475511 0.80 NR1H4 (0.38) AKR1C3NR1H4CHEK1POLA1KCNH2
SCHEMBL6670571 0.77 KDM4E (0.39) KCNH2PDE1BENPP2
SCHEMBL6974853 0.75 KCNH2 (0.47) POLA1KCNH2NPC1RAB9AENPP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004019940-A1 METHOD OF PREVENTING OR TREATING ATHEROSCLEROSIS OR RESTENOSIS PHARMACIA & UPJOHN COMPANY (US) 2004-03-11 WO claimed
WO-2004019940-A1 METHOD OF PREVENTING OR TREATING ATHEROSCLEROSIS OR RESTENOSIS PHARMACIA & UPJOHN COMPANY (US) 2004-03-11 WO disclosed